Menu
Log in
Forgot password


Log in
Forgot password

Please remember registration is not considered complete until payment has been received by the BBANYS Central Office. Upon receipt of payment, you will receive a confirmation email. If you have any questions, please contact bbanys@bbanys.org.

BBANYS Oct 8, 2025 Webinar - Adverse Outcomes of Blood Transfusions: Making the Case for Transfusion Avoidance in Modern Medical Practice

  • Wednesday, October 08, 2025
  • 3:00 PM - 4:00 PM
  • Online
  • 98

Registration

  • Includes access to all four sessions for current webinar series - do not need to register individually for other sessions in the series
  • Includes access to all four sessions for current webinar series - do not need to register individually for other sessions in the series
Register

Wednesday, October 8, 2025 / 3:00 PM - 4:00 PM EDT

Topic:
Adverse Outcomes of Blood Transfusions: Making the Case for Transfusion Avoidance in Modern Medical Practice

Speaker:
Mark T. Friedman, DO
Clinical Associate Professor of Pathology
Medical Director, Transfusion Service
NYU Langone Health, NYU Grossman Long Island School of Medicine

Speaker Bio:
Dr. Mark Friedman is a Clinical Associate Professor and Medical Director of Transfusion Services at NYU Langone Health, NYU Grossman Long Island School of Medicine in Mineola, NY. He has been in practice for nearly 30 years and has taught, published extensively, and lectured in the area of patient blood management. He is a past president of BBANYS and currently serves as the BBANYS Newsletter Editor. He also is currently serving as the AABB Chair of the TSO/PBM Subsection.

Abstract:

Historically, transfusion risks were focused on transmissible diseases, especially hepatitis B and non-A-non-B hepatitis transmission (later identified as hepatitis C), which carried up to a 10% risk in the 1960’s and early 1970’s, and HIV after its emergence in the 1980’s. Although vigilance must be maintained in keeping these transmissible diseases and others (for example, West Nile virus and babesiosis) out of the blood supply, much of the focus has shifted to reducing non-transmissible disease risks, including mistransfusion of ABO incompatible blood, transfusion-related acute lung injury (TRALI), transfusion-associated circulatory overload (TACO), and platelet component bacterial contamination, among others. Yet, beyond even these recognized risks, transfusions are associated with thromboembolic complications (acute myocardial infarction and stroke), immunomodulatory effects (with increased risk of perioperative infections), and increased length of hospital stay, as evidenced by data from the Western Australia Patient Blood Management Program (PBM). As a result, the World Health Organization (WHO) has urgently called for global implementation of PBM, evidence-based strategies to conserve patients’ own blood and reduce the need for blood transfusions, in its October 2021 Policy Brief.

Objectives:

At the end of this session, the learner will be able to:

  1. Recognize historical transfusion risks, such as hepatitis and HIV, in the current context.
  2. Explain the transition of transfusion risk reduction from transmissible diseases to non-transmissible disease risks.
  3. Analyze the case for transfusion avoidance in transfusion risk reduction.

Disclosures:

None

Pricing:
  • Members: FREE (Registration is required.)
  • Non-Members: $45 per session & $130 entire series
  • Institutions: $75 per session & $200 entire series

To receive member pricing, be sure to sign in.

BLOOD BANKS ASSOCIATION OF NEW YORK STATE
COPYRIGHT © 2025

CONTACT US
Phone: 866-397-8883
Fax: 651-317-8048
Email: bbanys@bbanys.org

ADDRESS
BBANYS
2345 Rice Street, Suite 220
St. Paul, MN 55113

Powered by Wild Apricot Membership Software